Asahi Kasei to integrate global pharmaceutical brands under Asahi Kasei Therapeutics

Asahi Kasei said Asahi Kasei Therapeutics in Japan, Veloxis Pharmaceuticals, Calliditas Therapeutics and AiCuris Anti-infective Cures will be brought together under one brand. The company said the move supports its goal of ¥300 billion in pharmaceutical net sales by FY2030.